Conditional excise exemption requires uniform claim across all covered clearances; selective availment is not permitted.

A conditional excise exemption tied to a statutory price list was interpreted as requiring a uniform claim for all covered clearances if the manufacturer wished to retain the benefit. The notification was not treated as an alternative valuation scheme under section 4(1)(a); instead, its proviso was held to be a clear condition applicable to every medicine in the price list, regardless of buyer class. Where the exemption was claimed only selectively, the benefit could not be confined to chosen clearances, and differential duty had to be worked out afresh on remand after hearing the assessee.

---

---

Issues: (i) Whether proviso (iii) to the exemption notification conflicted with section 4(1)(a) of the Central Excises Act, 1944 and permitted exemption to be claimed only for a particular class of buyers. (ii) Whether the manufacturer, having claimed the exemption only for some clearances, could be denied the benefit of the notification and made liable to differential duty on the relevant clearances.

Issue (i): Whether proviso (iii) to the exemption notification conflicted with section 4(1)(a) of the Central Excises Act, 1944 and permitted exemption to be claimed only for a particular class of buyers.

Analysis: Section 4(1)(a) permits different normal prices for different classes of buyers where the statutory conditions are satisfied. The notification, however, was not treated as prescribing an alternative mode of valuation. It granted a limited exemption by quantifying duty relief on the basis of the statutory retail price less 15% and required, as a condition for availing that relief, that the manufacturer claim exemption in respect of all medicines cleared by him whose retail price was specified in the statutory price list. The condition was found to be clear and unambiguous and applicable to all clearances covered by the price list, irrespective of the class of buyer.

Conclusion: There was no conflict between the notification and section 4(1)(a), and exemption could not be confined to a selected class of buyers.

Issue (ii): Whether the manufacturer, having claimed the exemption only for some clearances, could be denied the benefit of the notification and made liable to differential duty on the relevant clearances.

Analysis: The exemption was optional and had to be claimed for all medicines covered by the statutory price list if the manufacturer wished to retain its benefit. Since the manufacturer had not claimed the exemption uniformly, the approval of the price lists was not in order. The appropriate consequence was to deny the exemption where it had not been validly claimed and to require determination of differential duty on the clearances affected by that position. In the circumstances, the matter was remitted so that duty could be worked out afresh after giving particulars and hearing the assessee.

Conclusion: The impugned orders were set aside and the matter was remanded for fresh determination of differential duty, with the assessee denied the exemption only to the extent found applicable on remand.

Final Conclusion: The exemption notification was held to require an all-or-nothing claim for all covered clearances, but the duty liability had to be recomputed afresh on remand, resulting in relief to the assessee from the earlier demand structure and partial success on appeal.

Ratio Decidendi: A conditional exemption notification may require uniform claim of the benefit for all clearances covered by the statutory price list, and where that condition is not satisfied the exemption cannot be selectively availed for one class of buyers while retaining it for another.

---